Findings from a new study show that a thymidine phosphorylase (TYMP) inhibitor could help slow thrombosis in COVID-19 patients.
Findings from a new study show that a thymidine phosphorylase (TYMP) inhibitor could help slow thrombosis in COVID-19 patients.